Skip to main content
logo
Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
2.160
-0.074 (-3.31%)
Oct 30, 2026, 4:00 PM EDT - Market closed

Alterity Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
438760141122
Market Cap Growth
-40.26%44.59%327.48%23.14%-47.27%-50.72%
Enterprise Value
1753576-5-4
Last Close Price
2.165.374.091.812.796.11

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
17.1034.6516.785.224.366.11
PB Ratio
1.452.932.151.520.750.88
P/TBV Ratio
1.452.932.151.520.750.88

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
6.6421.0415.972.22--

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
0.010.010.000.010.010.00
Net Debt / Equity Ratio
-0.87-0.87-0.95-0.90-0.68-0.98
Net Debt / EBITDA Ratio
1.481.482.770.641.072.24
Net Debt / FCF Ratio
1.651.653.540.990.782.79
Asset Turnover
0.080.080.170.170.110.14
Quick Ratio
14.2614.2612.623.105.586.79
Current Ratio
14.5214.5212.983.546.177.07
Return on Equity (ROE)
-54.98%-54.98%-43.23%-104.47%-47.38%-38.97%
Return on Assets (ROA)
-34.08%-34.08%-28.09%-52.66%-26.64%-25.85%
Return on Capital Employed (ROCE)
-58.50%-58.50%-34.50%-141.60%-63.80%-43.60%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-43.41%-18.71%-13.31%-91.15%-80.84%-41.06%
FCF Yield
-37.06%-18.01%-12.55%-60.11%-117.35%-39.72%
Buyback Yield / Dilution
-64.53%-64.53%-75.31%-50.29%-0.91%-41.79%
SEC Filings: 10-K · 10-Q